Press and News
Industry Features
Press and News
Biotech firm Elucidata, backed by the likes of IvyCap Ventures and Hyperlane Venture, on Tuesday said it has raised $16 million in a series A round led by global investment firm, Eight Roads Ventures.
%201.svg){kind=icon}
.svg)
Big data-driven software platform reduces the time from experiment design to discovery through analysis and visualization of -omics drug discovery data.
BOSTON, Mass., Nov. 21, 2022 -- /PRNewswire/ – TetraScience, the Scientific Data Cloud company, announced today that Elucidata, whose data-centric platform Polly powers biological discovery with ML-ready biomedical data
From young startups to major conglomerates, almost every organization in the life sciences industry is looking at AI to drive R&D and come up with and therapies.
.svg){kind=logo}
CAMBRIDGE, Mass., Sept. 27, 2022 /PRNewswire/ -- Elucidata, a TechBio company that powers life science research & development (R&D) with its data-centric Machine Learning Operations (ML-Ops) platform, Polly,
.svg)
Elucidata, a Cambridge, MA-based TechBio company that powers life science research and development (R&D) with its data-centric Machine Learning Operations (ML-Ops) platform, Polly, announced that it raised $16 million in Series A funding.
The round was led by Eight Roads Ventures, with participation from F-Prime Capital, IvyCap Ventures, and Hyperplane Venture Capital
The funds raised will be used by Elucidata’s data-centric Machine Learning Operations (ML-Ops) platform, Polly to deepen product capabilities in translational drug research and allied markets,
Elucidata, the data science start-up focused on making better drugs, faster, has announced its plans to double its workforce by 2019.
New Delhi [India] June 19 (ANI/NewsVoir): Elucidata, the data science start-up focused on making better drugs, faster, has announced its plan to double its workforce by 2019.
Featured Posts
© All Rights Reserved, 2023
